323 related articles for article (PubMed ID: 22912725)
1. Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.
Ozen E; Gozukizil A; Erdal E; Uren A; Bottaro DP; Atabey N
PLoS One; 2012; 7(8):e42717. PubMed ID: 22912725
[TBL] [Abstract][Full Text] [Related]
2. Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway.
Xiang QF; Zhan MX; Li Y; Liang H; Hu C; Huang YM; Xiao J; He X; Xin YJ; Chen MS; Lu LG
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):83-89. PubMed ID: 30663411
[TBL] [Abstract][Full Text] [Related]
3. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis.
Bozkaya G; Korhan P; Cokaklı M; Erdal E; Sağol O; Karademir S; Korch C; Atabey N
Mol Cancer; 2012 Sep; 11():64. PubMed ID: 22962849
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
[TBL] [Abstract][Full Text] [Related]
5. Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression.
Lee BS; Kang S; Kim KA; Song YJ; Cheong KH; Cha HY; Kim CH
Cell Death Dis; 2014 Apr; 5(4):e1159. PubMed ID: 24722284
[TBL] [Abstract][Full Text] [Related]
6. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.
Tan S; Li R; Ding K; Lobie PE; Zhu T
FEBS Lett; 2011 Jul; 585(14):2229-34. PubMed ID: 21658389
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.
Abiru S; Nakao K; Ichikawa T; Migita K; Shigeno M; Sakamoto M; Ishikawa H; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2002 May; 35(5):1117-24. PubMed ID: 11981761
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.
Gui Y; Khan MGM; Bobbala D; Dubois C; Ramanathan S; Saucier C; Ilangumaran S
World J Gastroenterol; 2017 Sep; 23(36):6639-6649. PubMed ID: 29085209
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory action of naphtho[1,2-b]furan-4,5-dione on hepatocyte growth factor-induced migration and invasion of MDA-MB-231 cells: mechanisms of action.
Tsai PC; Chu CL; Tseng CH; Chen YL; Chang LS; Lin SR
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):716-26. PubMed ID: 24909202
[TBL] [Abstract][Full Text] [Related]
10. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X
J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476
[TBL] [Abstract][Full Text] [Related]
11. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1.
Jiang Y; Xu W; Lu J; He F; Yang X
Biochem Biophys Res Commun; 2001 Sep; 286(5):1123-30. PubMed ID: 11527416
[TBL] [Abstract][Full Text] [Related]
12. Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells.
Firtina Karagonlar Z; Koc D; Iscan E; Erdal E; Atabey N
Cancer Sci; 2016 Apr; 107(4):407-16. PubMed ID: 26790028
[TBL] [Abstract][Full Text] [Related]
13. Nobiletin attenuates metastasis via both ERK and PI3K/Akt pathways in HGF-treated liver cancer HepG2 cells.
Shi MD; Liao YC; Shih YW; Tsai LY
Phytomedicine; 2013 Jun; 20(8-9):743-52. PubMed ID: 23537747
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal activating crosstalk between c-Met and caveolin 1 promotes invasive phenotype in hepatocellular carcinoma.
Korhan P; Erdal E; Kandemiş E; Cokaklı M; Nart D; Yılmaz F; Can A; Atabey N
PLoS One; 2014; 9(8):e105278. PubMed ID: 25148256
[TBL] [Abstract][Full Text] [Related]
15. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway.
Chen K; Zhang S; Ji Y; Li J; An P; Ren H; Liang R; Yang J; Li Z
PLoS One; 2013; 8(9):e72927. PubMed ID: 24039823
[TBL] [Abstract][Full Text] [Related]
16. Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression.
Fu R; Jiang S; Li J; Chen H; Zhang X
Med Oncol; 2020 Mar; 37(4):24. PubMed ID: 32166604
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxin III suppresses hepatocyte growth factor-stimulated migration and invasion of MDA-MB-231 cells.
Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
Cell Biochem Funct; 2014 Aug; 32(6):485-95. PubMed ID: 24964901
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of epidermal growth factor and hepatocyte growth factor on human ovarian cancer cell invasion and migration: role of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.
Zhou HY; Pon YL; Wong AS
Endocrinology; 2007 Nov; 148(11):5195-208. PubMed ID: 17673518
[TBL] [Abstract][Full Text] [Related]
19. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
Knowles LM; Stabile LP; Egloff AM; Rothstein ME; Thomas SM; Gubish CT; Lerner EC; Seethala RR; Suzuki S; Quesnelle KM; Morgan S; Ferris RL; Grandis JR; Siegfried JM
Clin Cancer Res; 2009 Jun; 15(11):3740-50. PubMed ID: 19470725
[TBL] [Abstract][Full Text] [Related]
20. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
Menakongka A; Suthiphongchai T
World J Gastroenterol; 2010 Feb; 16(6):713-22. PubMed ID: 20135719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
